| P2093 | author name string | F Laliberté | |
| | P Lefebvre | |
| | G Germain | |
| | W H Olson | |
| | C Crivera | |
| | J R Schein | |
| | K Dea | |
| | L E Fields | |
| | S M Lynch | |
| | Y-W Ma | |
| P2860 | cites work | Heart disease and stroke statistics--2012 update: a report from the American Heart Association | Q29547909 |
| | Ticagrelor versus clopidogrel in patients with acute coronary syndromes | Q29619002 |
| | Toward evidence-based medical statistics. 2: The Bayes factor | Q33866194 |
| | Toward evidence-based medical statistics. 1: The P value fallacy | Q33866199 |
| | Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population | Q36821026 |
| | Estimating medical costs from incomplete follow-up data | Q36866750 |
| | Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology | Q38079124 |
| | Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial | Q46105774 |
| | Prasugrel versus clopidogrel in patients with acute coronary syndromes | Q46915044 |
| P433 | issue | 6 | |
| P921 | main subject | acute coronary syndrome | Q266018 |
| | clopidogrel | Q410237 |
| P304 | page(s) | 663-672 | |
| P577 | publication date | 2014-09-23 | |
| P1433 | published in | Journal of Clinical Pharmacy and Therapeutics | Q15753553 |
| P1476 | title | Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel. | |
| P478 | volume | 39 | |